One year after becoming available for older Americans and pregnant women, receptive public opinion of respiratory syncytial ...

Respiratory syncytial virus (RSV) is on the rise in Indiana, according to the Centers for Disease Control and Prevention, and ...

Covering coughs and sneezes and washing your hands can help prevent infections, according to the New York City health ...

Respiratory syncytial virus, or RSV, is a common respiratory virus that infects the nose, throat, and lungs. According to the ...

Respiratory viruses typically experience their highest levels in the wintertime, and this year will likely be no different.

Respiratory Syncytial Virus season is expected to peak between now and early March. RSV is the leading cause of respiratory ...

But enrollment for all clinical studies of infant RSV vaccines is now on hold due to safety concerns, explained a Dec. 11 ...

RSV prevention among children, including nirsevimab and the maternal RSVpreF vaccine, may be associated with a reduction in pediatric ICU utilization.

More than half of U.S. adults (52%) think the RSV vaccine given to pregnant women will protect newborns from the infection, ...

Respiratory Syncytial Virus Prefusion F (RSVpreF) vaccination is effective against RSV-related lower respiratory tract ...

Respiratory syncytial virus (RSV) is a major cause of respiratory infections, particularly in infants, children under 5 years, and older adults. Its rapid spread makes RSV a serious public health ...

An FDA approval of Merck’s drug clesrovimab by June would give physicians another option for protecting newborns from ...